BioCentury
ARTICLE | Clinical News

AVI preclinical data

December 3, 2001 8:00 AM UTC

AVII said its NeuGene calicivirus-specific antisense compound reduced viral replication and subsequent cell death in a dose-dependent manner in pig and monkey cells in vitro. AVII noted that the antis...